Health Kick Podcast: Creating hope for debilitating diseases

Stockhead’s health and biotech expert Tim Boreham is back in the studio for another instalment of the Health Kick Podcast.

In this episode Tim chats with Tim Oldham, CEO and managing director at AdAlta (ASX:1AD).

The biotech company is devoted to the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic diseases, for which there’s no cure.

A new, more effective, and longer-lasting treatment regime using i-bodies would bring hope to hundreds of thousands of patients worldwide – cue AdAlta!

Tune in below!

On mobile? Click here to listen with Apple podcasts, or here for Spotify.

Like to tune in through another app? Just search for Health Kick Podcast with Tim Boreham and subscribe!

This podcast was developed in collaboration with AdAlta, a Stockhead advertiser at the time of publishing.

The interviews and discussions in this podcast are opinions only and not financial or investment advice. Listeners should obtain independent advice based on their own circumstances before making any financial decisions.